Optimal cumulative cisplatin dose during concurrent chemoradiotherapy among children and adolescents with locoregionally advanced nasopharyngeal carcinoma: A real-world data study-Reference-Cited by-同舟云学术

Optimal cumulative cisplatin dose during concurrent chemoradiotherapy among children and adolescents with locoregionally advanced nasopharyngeal carcinoma: A real-world data study

Published:2021-08 Issue: Volume:161 Page:83-91
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Jin Ya-Nan,Yao Ji-Jin,You Ya-Fei,Cao Hui-Jiao,Li Zi-Zi,Dai Dan-Ling,Zhang Wang-Jian,Marks Tia,Zhang Bei,Xia Liang-Ping

Funder

National Natural Science Foundation of China

Medical Science and Technology Foundation of Guangdong Province

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference31 articles.

1. Childhood nasopharyngeal carcinoma: state-of-the-art, and questions for the future;Dourthe;J Pediatr Hematol Oncol,2018

2. Undifferentiated nasopharyngeal carcinoma in children and adolescents: comparison between staging systems;Casanova;Ann Oncol,2001

3. Head and neck cancers, version 2.2020, NCCN Clinical Practice Guidelines in Oncology;Pfister;J Natl Compr Canc Netw,2020

4. Treatment of childhood nasopharyngeal carcinoma with induction chemotherapy and concurrent chemoradiotherapy: results of the Children's Oncology Group ARAR0331 study;Rodriguez-Galindo;J Clin Oncol,2019

5. Comparison of long-term outcomes and sequelae between children and adult nasopharyngeal carcinoma treated with intensity modulated radiation therapy;Chen;Int J Radiat Oncol Biol Phys,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer therapy-induced adverse drug reactions in children and preventive and control measures;Frontiers in Pharmacology;2024-02-15

2. Concurrent chemoradiotherapy with or without neoadjuvant chemotherapy in pediatric patients with stage III-IVa nasopharyngeal carcinoma: a real-world propensity score-matched cohort study;Journal of Cancer Research and Clinical Oncology;2023-07-07

3. Response to the letter by Dr Sari regarding the article “The feasibility of reduced-dose radiotherapy in childhood nasopharyngeal carcinoma with favorable response to neoadjuvant chemotherapy”;Radiotherapy and Oncology;2023-04

4. The feasibility of reduced-dose radiotherapy in childhood nasopharyngeal carcinoma with favorable response to neoadjuvant chemotherapy;Radiotherapy and Oncology;2023-01

5. Development of a web-based prognostic model to quantify the survival benefit of cumulative cisplatin dose during concurrent chemoradiotherapy in childhood nasopharyngeal carcinoma;Radiotherapy and Oncology;2022-01